Ryman Healthcare (ASX:RYM) FFO


ASX:RYM Ryman Healthcare Ltd ASX:RYM
51 GF Score
Price A$1.87
GF Value A$4.71
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Ryman Healthcare FFO?

FFO (Funds from operations) only applies to REITs.

ASX:RYM
51GF Score
Ryman Healthcare Ltd ASX:RYM
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ryman Healthcare (ASX:RYM) Overvalued in 2026?

Based on GuruFocus' analysis, Ryman Healthcare stock appears to be undervalued. The current stock price of A$1.87 is trading 60.3% below its estimated GF Value™ of A$4.71. GuruFocus considers Ryman Healthcare to be Possible Value Trap.

Key valuation signals for ASX:RYM:

  • FFO:
  • GF Value™: A$4.71 vs. price of A$1.87 (60.3% below fair value)
  • GF Score™: 51/100 with 2 warning signs

No single metric tells the full story. See the ASX:RYM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ryman Healthcare Business Description

Other Exchanges RYM:New ZealandRH7:Germany
Address 92 Russley Road, P.O. Box 771, Christchurch, CT, NZL, 8042
Ryman Healthcare Ltd is a retirement living and aged care provider operating in New Zealand and Australia. It owns and operates integrated retirement villages through its trading subsidiaries, which operate in the aged care and retirement living sector in New Zealand and Australia. The Group operates in a single industry: the provision of integrated retirement living and aged care for older people in New Zealand and Australia. The majority of revenue is derived from Care and village fees, which relate to the provision of accommodation, care and related services to aged care residents and retirement living residents.
51GF Score

Get the complete analysis for ASX:RYM

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.87
Price
A$4.71
GF Value